Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    "methodist hospital" | Open Studies | "Vascular Diseases" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting Registry of the Magellan Robotic System
Condition: Peripheral Vascular Disease
Intervention:
2 Available Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access
Conditions: Peripheral Arterial Disease;   Peripheral Vascular Diseases;   Critical Limb Ischemia
Intervention: Device: Bone marrow concentration device
3 Recruiting TUMOR-ASSOCIATED ANTIGEN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR MULTIPLE MYELOMA
Condition: Multiple Myeloma
Intervention: Biological: TAA-specific CTLs
4 Recruiting Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
Conditions: Lymphoma;   Myeloma;   Leukemia
Intervention: Biological: Kappa CD28 T cells
5 Recruiting Reducing Radioisotope Dose: the Half-Dose CZT Study
Condition: Coronary Artery Disease
Intervention: Other: Half-dose isotope for NuclearStressTest
6 Recruiting Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: regadenoson
7 Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
8 Recruiting Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Condition: Nonarteritic Anterior Ischemic Optic Neuropathy
Interventions: Drug: QPI-1007 Injection - single low dose;   Drug: QPI-1007 Injection - single high dose;   Drug: QPI-1007 Injection - multiple low dose;   Drug: QPI-1007 Injection - multiple high dose;   Other: Sham Injection Procedure
9 Recruiting Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System
Condition: Peripheral Arterial Disease
Intervention: Device: BioMimics 3D Stent System
10 Recruiting ABSORB III Randomized Controlled Trial (RCT)
Conditions: Coronary Artery Disease;   Coronary Artery Stenosis;   Coronary Disease;   Coronary Stenosis
Interventions: Device: Absorb BVS;   Device: XIENCE
11 Recruiting Neuroform Atlas IDE Study
Condition: Intracranial Aneurysm
Intervention: Device: Next Generation Neuroform Stent System
12 Recruiting Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
Condition: Carotid Stenosis
Interventions: Procedure: Carotid endarterectomy;   Device: Carotid stenting
13 Recruiting Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Condition: Cerebral Hemorrhage
Intervention:
14 Recruiting A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
Conditions: Catecholamine-resistant Hypotension (CRH);   Distributive Shock;   High Output Shock;   Sepsis
Interventions: Drug: LJPC-501;   Drug: Placebo
15 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
16 Recruiting Zenith® p-Branch® Endovascular Graft Pivotal Study
Condition: Aortic Aneurysm Abdominal
Intervention: Device: Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents
17 Recruiting Coronary InterventionS in HIgh-Risk PatiEnts Using a Novel Percutaneous Left Ventricular Support Device (SHIELD II)
Condition: Coronary Artery Disease
Interventions: Device: HeartMate PHP;   Device: Abiomed Impella® Recover® LP 2.5
18 Recruiting Stroke AF - Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
Condition: Stroke, Acute
Intervention: Device: Reveal LINQ™ Insertable Cardiac Monitor
19 Recruiting A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ubenimex;   Other: placebo
20 Recruiting The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan;   Drug: Tadalafil;   Drug: Selexipag

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years